Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain - Fox Business
Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain Fox Business BioNTech testing Pfizer COVID-19 vaccine against B.1.1.529 variant Business Insider Merck says its Covid antiviral treatment less effective than first thought Financial Times BioNTech says it will know vaccine's effectiveness against new variant in two weeks | TheHill The Hill With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan RealMoney View Full Coverage on Google News from Top stories - Google News November 27, 2021 at 12:54AM